Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma

BACKGROUND: The efficacy of autologous stem-cell transplantation during the first remission in patients with diffuse, aggressive non-Hodgkin's lymphoma classified as high-intermediate risk or high risk on the International Prognostic Index remains controversial and is untested in the rituximab...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Stiff, Patrick J., Unger, Joseph M., Cook, James R., Constine, Louis S., Couban, Stephen, Stewart, Douglas A., Shea, Thomas C., Porcu, Pierluigi, Winter, Jane N., Kahl, Brad S., Miller, Thomas P., Tubbs, Raymond R., Marcellus, Deborah, Friedberg, Jonathan W., Barton, Kevin P., Mills, Glenn M., LeBlanc, Michael, Rimsza, Lisa M., Forman, Stephen J., Fisher, Richard I., M.D
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2013
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3985418/
https://ncbi.nlm.nih.gov/pubmed/24171516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1301077
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items